NYSE:WATLife Sciences
Assessing Waters (WAT) Valuation After ARES G3 Launch And Earnings Beat
What the latest ARES-G3 launch and earnings beat mean for Waters (WAT)
Waters (WAT) just rolled out its ARES-G3 Rheometer while also reporting fourth quarter results that topped expectations and came with positive sales and earnings guidance for the next few quarters.
See our latest analysis for Waters.
Even with the ARES-G3 launch and an earnings beat in the background, Waters’ share price has been under pressure, with a 30 day share price return of 9.33% decline and a 1 year total...